Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Research output: Contribution to journal › Comment/debate › Research
Documents
- Fulltext
Final published version, 491 KB, PDF document
Original language | English |
---|---|
Article number | e120 |
Journal | Diabetes Care |
Volume | 46 |
Issue number | 5 |
Number of pages | 1 |
ISSN | 0149-5992 |
DOIs |
|
Publication status | Published - 2023 |
ID: 347742448